Sleep duration, insomnia, and markers of systemic inflammation: Results from the Netherlands Study of Depression and Anxiety (NESDA)

Journal of Psychiatric Research

Volumn 60, Issue , 2015, Pages 95-102

  Prather, Aric A ^a   Vogelzangs, Nicole ^b   Penninx, Brenda W J H ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Anxiety; Depression; Inflammation; Insomnia; Sleep duration

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 6; MIRTAZAPINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; ANXIETY DISORDER; ARTICLE; BODY MASS; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DRUG USE; EDUCATIONAL STATUS; FEMALE; HUMAN; INFLAMMATION; INSOMNIA; MAJOR CLINICAL STUDY; MALE; RECURRENT DISEASE; REMISSION; SELF REPORT; SEX DIFFERENCE; SLEEP TIME; SMOKING; STATISTICAL SIGNIFICANCE; ADOLESCENT; ANXIETY; BLOOD; EPIDEMIOLOGY; IMMUNOLOGY; MIDDLE AGED; NETHERLANDS; PSYCHOLOGY; REGRESSION ANALYSIS; SLEEP; TIME FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANXIETY; BIOMARKERS; C-REACTIVE PROTEIN; DEPRESSION; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; NETHERLANDS; REGRESSION ANALYSIS; SEX FACTORS; SLEEP; SLEEP INITIATION AND MAINTENANCE DISORDERS; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84919327068     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2014.09.018     Document Type: Article

References (56)

1. Ayas N.T., White D.P., Al-Delaimy W.K., Manson J.E., Stampfer M.J., Speizer F.E., et al. Aprospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care 2003, 26:380-384.
2. Ayas N.T., White D.P., Manson J.E., Stampfer M.J., Speizer F.E., Malhotra A., et al. Aprospective study of sleep duration and coronary heart disease in women. Arch Intern Med 2003, 163:205-209.
3. Bryant P.A., Trinder J., Curtis N. Sick and tired: does sleep have a vital role in the immune system?. Nat Rev Immunol 2004, 4:457-467.
4. Burgos I., Richter L., Klein T., Fiebich B., Feige B., Lieb K., et al. Increased nocturnal interleukin-6 excretion in patients with primary insomnia: a pilot study. Brain Behav Immun 2006, 20:246-253.
5. Cappuccio F.P., D'Elia L., Strazzullo P., Miller M.A. Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care 2010, 33:414-420.
6. Cappuccio F.P., D'Elia L., Strazzullo P., Miller M.A. Sleep duration and all-cause mortality: a systematic review and meta-analysis of prospective studies. Sleep 2010, 33:585-592.
7. Carrillo-Vico A., Lardone P.J., Alvarez-Sanchez N., Rodriguez-Rodriguez A., Guerrero J.M. Melatonin: buffering the immune system. Int J Mol Sci 2013, 14:8638-8683.
8. Craig C.L., Marshall A.L., Sjostrom M., Bauman A.E., Booth M.L., Ainsworth B.E., et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003, 35:1381-1395.
9. de Graaf R., Bijl R.V., Spijker J., Beekman A.T., Vollebergh W.A. Temporal sequencing of lifetime mood disorders in relation to comorbid anxiety and substance use disorders - findings from the Netherlands Mental Health Survey and Incidence Study. Soc Psychiatry Psychiatr Epidemiol 2003, 38:1-11.
10. Dowd J.B., Goldman N., Weinstein M. Sleep duration, sleep quality, and biomarkers of inflammation in a Taiwanese population. Ann Epidemiol 2011, 21:799-806.
11. Dowlati Y., Herrmann N., Swardfager W., Liu H., Sham L., Reim E.K., et al. Ameta-analysis of cytokines in major depression. Biol Psychiatry 2010, 67:446-457.
12. Eaton W.W., Armenian H., Gallo J., Pratt L., Ford D.E. Depression and risk for onset of type II diabetes. A prospective population-based study. Diabetes Care 1996, 19:1097-1102.
13. Franzen P.L., Buysse D.J. Sleep disturbances and depression: risk relationships for subsequent depression and therapeutic implications. Dialogues Clin Neurosci 2008, 10:473-481.
14. Garcia-Maurino S., Gonzalez-Haba M.G., Calvo J.R., Rafii-El-Idrissi M., Sanchez-Margalet V., Goberna R., et al. Melatonin enhances IL-2, IL-6, and IFN-gamma production by human circulating CD4+ cells: a possible nuclear receptor-mediated mechanism involving T helper type 1 lymphocytes and monocytes. JImmunol 1997, 159:574-581.
15. Goldberg D. The heterogeneity of "major depression". World Psychiatr: Off J World Psychiatr Assoc 2011, 10:226-228.
16. Grandner M.A., Buxton O.M., Jackson N., Sands-Lincoln M., Pandey A., Jean-Louis G. Extreme sleep durations and increased C-reactive protein: effects of sex and ethnoracial group. Sleep 2013, 36. 769-79E.
17. Grandner M.A., Drummond S.P. Who are the long sleepers? Towards an understanding of the mortality relationship. Sleep Med Rev 2007, 11:341-360.
18. Hall M.H., Muldoon M.F., Jennings J.R., Buysse D.J., Flory J.D., Manuck S.B. Self-reported sleep duration is associated with the metabolic syndrome in midlife adults. Sleep 2008, 31:635-643.
19. Harvey A.G., Murray G., Chandler R.A., Soehner A. Sleep disturbance as transdiagnostic: consideration of neurobiological mechanisms. Clin Psychol Rev 2011, 31:225-235.
20. Heslop P., Smith G.D., Metcalfe C., Macleod J., Hart C. Sleep duration and mortality: the effect of short or long sleep duration on cardiovascular and all-cause mortality in working men and women. Sleep Med 2002, 3:305-314.
21. Horne J. The end of sleep: 'sleep debt' versus biological adaptation of human sleep to waking needs. Biol Psychol 2011, 87:1-14.
22. Howren M.B., Lamkin D.M., Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 2009, 71:171-186.
23. Insel T.R., Wang P.S. Rethinking mental illness. JAMA: J Am Med Assoc 2010, 303:1970-1971.
24. Irwin M., Wang M., Campomayor C.O., Collado-Hidalgo A., Cole S. Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation. Arch Intern Med 2006, 166:1756-1762.
25. Jacobi F., Wittchen H.U., Holting C., Hofler M., Pfister H., Muller N., et al. Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS). Psychol Med 2004, 34:597-611.
26. Kessler R.C., McGonagle K.A., Zhao S., Nelson C.B., Hughes M., Eshleman S., et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994, 51:8-19.
27. Lett H.S., Blumenthal J.A., Babyak M.A., Sherwood A., Strauman T., Robins C., et al. Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment. Psychosom Med 2004, 66:305-315.
28. Levine D.W., Kaplan R.M., Kripke D.F., Bowen D.J., Naughton M.J., Shumaker S.A. Factor structure and measurement invariance of the Women's Health Initiative Insomnia Rating Scale. Psychol Assess 2003, 15:123-136.
29. Levine D.W., Kripke D.F., Kaplan R.M., Lewis M.A., Naughton M.J., Bowen D.J., et al. Reliability and validity of the Women's Health Initiative Insomnia Rating Scale. Psychol Assess 2003, 15:137-148.
30. Matthews K.A., Zheng H., Kravitz H.M., Sowers M., Bromberger J.T., Buysse D.J., et al. Are inflammatory and coagulation biomarkers related to sleep characteristics in mid-life women?: study of Women's Health across the Nation sleep study. Sleep 2010, 33:1649-1655.
31. Miller M.A., Kandala N.B., Kivimaki M., Kumari M., Brunner E.J., Lowe G.D., et al. Gender differences in the cross-sectional relationships between sleep duration and markers of inflammation: Whitehall II study. Sleep 2009, 32:857-864.
32. Morrey K.M., McLachlan J.A., Serkin C.D., Bakouche O. Activation of human monocytes by the pineal hormone melatonin. JImmunol 1994, 153:2671-2680.
33. Motivala S.J., Sarfatti A., Olmos L., Irwin M.R. Inflammatory markers and sleep disturbance in major depression. Psychosom Med 2005, 67:187-194.
34. O'Donovan A., Hughes B.M., Slavich G.M., Lynch L., Cronin M.T., O'Farrelly C., et al. Clinical anxiety, cortisol and interleukin-6: evidence for specificity in emotion-biology relationships. Brain Behav Immun 2010, 24:1074-1077.
35. O'Donovan A., Slavich G.M., Epel E.S., Neylan T.C. Exaggerated neurobiological sensitivity to threat as a mechanism linking anxiety with increased risk for diseases of aging. Neurosci Biobehav Rev 2013, 37:96-108.
36. Patel S.R., Blackwell T., Ancoli-Israel S., Stone K.L. Sleep characteristics of self-reported long sleepers. Sleep 2012, 35:641-648.
37. Patel S.R., Malhotra A., Gottlieb D.J., White D.P., Hu F.B. Correlates of long sleep duration. Sleep 2006, 29:881-889.
38. Patel S.R., Zhu X., Storfer-Isser A., Mehra R., Jenny N.S., Tracy R., et al. Sleep duration and biomarkers of inflammation. Sleep 2009, 32:200-204.
39. Penninx B.W., Beekman A.T., Smit J.H., Zitman F.G., Nolen W.A., Spinhoven P., et al. The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods. Int J Methods Psychiatr Res 2008, 17:121-140.
40. Raikkonen K., Matthews K.A., Kuller L.H. Depressive symptoms and stressful life events predict metabolic syndrome among middle-aged women: a comparison of World Health Organization, Adult Treatment Panel III, and International Diabetes Foundation definitions. Diabetes Care 2007, 30:872-877.
41. Shearer W.T., Reuben J.M., Mullington J.M., Price N.J., Lee B.N., Smith E.O., et al. Soluble TNF-alpha receptor 1 and IL-6 plasma levels in humans subjected to the sleep deprivation model of spaceflight. JAllergy Clin Immunol 2001, 107:165-170.
42. Solarz D.E., Mullington J.M., Meier-Ewert H.K. Sleep, inflammation and cardiovascular disease. Front Biosci 2012, 4:2490-2501.
43. Suls J., Bunde J. Anger, anxiety, and depression as risk factors for cardiovascular disease: the problems and implications of overlapping affective dispositions. Psychol Bull 2005, 131:260-300.
44. Taheri S., Austin D., Lin L., Nieto F.J., Young T., Mignot E. Correlates of serum C-reactive protein (CRP)-no association with sleep duration or sleep disordered breathing. Sleep 2007, 30:991-996.
45. van Mill J.G., Hoogendijk W.J., Vogelzangs N., van Dyck R., Penninx B.W. Insomnia and sleep duration in a large cohort of patients with major depressive disorder and anxiety disorders. JClin Psychiatry 2010, 71:239-246.
46. Vgontzas A.N., Papanicolaou D.A., Bixler E.O., Lotsikas A., Zachman K., Kales A., et al. Circadian interleukin-6 secretion and quantity and depth of sleep. JClin Endocrinol Metab 1999, 84:2603-2607.
47. Vgontzas A.N., Zoumakis E., Bixler E.O., Lin H.M., Follett H., Kales A., et al. Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. JClin Endocrinol Metab 2004, 89:2119-2126.
48. Vogelzangs N., Beekman A.T., de Jonge P., Penninx B.W. Anxiety disorders and inflammation in a large adult cohort. Transl Psychiatry 2013, 3:e249.
49. Vogelzangs N., Duivis H.E., Beekman A.T., Kluft C., Neuteboom J., Hoogendijk W., et al. Association of depressive disorders, depression characteristics and antidepressant medication with inflammation. Transl Psychiatry 2012, 2:e79.
50. Vogelzangs N., Seldenrijk A., Beekman A.T., van Hout H.P., de Jonge P., Penninx B.W. Cardiovascular disease in persons with depressive and anxiety disorders. JAffect Disord 2010, 125:241-248.
51. Williams C.J., Hu F.B., Patel S.R., Mantzoros C.S. Sleep duration and snoring in relation to biomarkers of cardiovascular disease risk among women with type 2 diabetes. Diabetes Care 2007, 30:1233-1240.
52. Wittchen H.U. Reliability and validity studies of the WHO-Composite International Diagnostic Interview (CIDI): a critical review. JPsychiatr Res 1994, 28:57-84.
53. Youngstedt S.D., Jean-Louis G. Long sleep a greater mortality risk than short sleep in older adults. JAm Geriatr Soc 2011, 59:957-958.
54. Youngstedt S.D., Jean-Louis G., Bootzin R.R., Kripke D.F., Cooper J., Dean L.R., et al. Chronic moderate sleep restriction in older long sleepers and older average duration sleepers: a randomized controlled trial. Contemp Clin Trials 2013, 36:175-186.
55. Youngstedt S.D., Kripke D.F. Long sleep and mortality: rationale for sleep restriction. Sleep Med Rev 2004, 8:159-174.
56. Zorrilla E.P., Luborsky L., McKay J.R., Rosenthal R., Houldin A., Tax A., et al. The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav Immun 2001, 15:199-226.